Bristol-Myers ends development of hepatitis C drug after test patient dies of heart failure

NEW YORK, N.Y. - Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure....More